Rising Clinical Trial Numbers Fuel Growth In The ATMP CDMO Market Driving Market Acceleration in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size By 2025?
The market size for contract development and manufacturing organization (CDMO) of advanced therapy medicinal products has seen a significant surge in growth recently. The market, which was valued at $5.31 billion in 2024, is predicted to expand to $6.22 billion in 2025, providing a compound annual growth rate (CAGR) of 17.0%. This robust growth during the historical period is credited to factors like an increase in ATMP clinical trials, heightened understanding and assurance in the scientific community about the advantages of advanced therapy, the existence of many ATMP CDMOs, escalated efforts in bringing forth new therapies for various diseases, and encouraging governmental policies and initiatives.

How Big Is the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Expected to Grow by 2029?
The size of the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market is predicted to experience substantial expansion in the upcoming years, expecting to reach $11.53 billion in 2029 with a compound annual growth rate (CAGR) of 16.7%. This growth during the predicted period could be a result of the substantial investments made by CDMOs, an increase in new competitors in the cell and gene therapy (CGT) sector, a rise in grants and investments aimed towards the progression of cell and gene therapies, an uptick in pharmaceutical R&D expenditure, and a surge in clinical trials involving ATMPs. Notable trends during this predicted period consist of developments in AAV biomanufacturing facilities, the expansion of cell and gene therapy production, technological progress in cell and gene therapy, a growing need for advanced platforms and technologies, and the incorporation of advanced technologies, including CRISPR and next-generation sequencing, to improve accuracy.

View the full report here:
https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

Which Key Market Drivers Powering Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Expansion and Growth?
The growth of the advanced therapy medicinal products CDMO market seems to be driven by the escalating count of clinical trials. Clinical trials, which are research studies involving human subjects designed to assess the safety and effectiveness of medical interventions, have seen an uptick to fulfill the growing need for novel treatments and address the burgeoning global disease load. As the use of advanced therapy medicinal products increases, the demand for CDMO manufacturing services is also ramped up, utilizing unique expertise and infrastructure. The information gathered from clinical trials aids in refining manufacturing processes, ensuring both scalability and preservation of quality to cater to larger clinical and commercial requirements. For instance, per the Association of the British Pharmaceutical Industry, a trade association based in the UK, the total number of industry clinical trials initiated in the UK annually saw a minor increase of 4.3%, from 394 in 2021 to 411 in 2022. Consequently, the rising count of clinical trials is fuelling the growth of the advanced therapy medicinal products CDMO market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Leading corporations in the advanced therapy medicinal products CDMO industry are innovating advanced cell therapy fabrication services to resolve major concerns in cell therapy production and hasten the progress endeavors of their associates. These services play a crucial role in contract development and manufacturing organizations, offering a wide spectrum of services ranging from preliminary preclinical development to sophisticated clinical trials and commercialization. To illustrate, Pluristem Therapeutics Inc., a pioneering biotech corporation from Israel, unveiled PluriCDMO in January 2024. This new business division specializes in cell therapy fabrication, using a patented bioreactor system for 3D cell multiplication to accommodate the production of various cell types like stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO aspires to deliver top-notch, essential medicines to patients, ensuring unique consistency between each batch in a scalable, cost-effective fashion under good manufacturing practice conditions.

What Are the Emerging Segments in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented -

1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp

Who Are the Global Leaders in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

Which are the Top Profitable Regional Markets for the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Industry?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15719

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.